RenovoRx (RNXT) Other Non-Current Assets (2020 - 2026)

RenovoRx (RNXT) posted Other Non-Current Assets of $4000.0 for Q3 2021, little changed sequentially from $4000.0 in Q4 2020.

RenovoRx (RNXT) Other Non-Current Assets (2020 - 2026) Analysis & Trends

RenovoRx has reported Other Non-Current Assets for 2 years, with the latest figure at $4000.0 in Q3 2021.

Quarterly Other Non-Current Assets changed N/A year-over-year to $4000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $4000.0 (changed N/A YoY) and the FY2020 annual result came in at $4000.0, changed N/A from the prior year.
Other Non-Current Assets was little changed at $4000.0 in Q3 2021 per RNXT's latest filing, from $4000.0 in the prior quarter.
Over five years, Other Non-Current Assets peaked at $4000.0 in Q4 2020 and troughed at $4000.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	1.25 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	2.31 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	124.00 Mn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	618.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	109.58 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	65.13 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	104.44 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	62.96 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	202.31 Mn
10	RenovoRx	61.96 Mn	61.96 Mn	766,000.00	200,000.00

Download Data